precision oncology

Oncology

How AI is advancing patient subgroup identification in oncol...

With the advent of AI, it’s now possible to enrich clinical trials for patient subgroups more precisely than ever before.

Oncology

Why precision biomarkers will change the future of breast ca...

Blood-based biomarkers can provide an earlier, dynamic view of what is happening inside a patient, creating an opportunity to detect changes sooner.

R&D

Clinical Trials Round-Up: July/August 2026

While the volume of announcements hit a mid-year slump, July and August still produced an exciting array of updates across the drug development arena.

Oncology

Establishing ctDNA as a validated primary surrogate endpoint

Circulating tumour DNA (ctDNA) has emerged as a promising primary surrogate endpoint in solid tumour oncology.

Oncology

Bridging the cancer drug development gap: AI-driven precisio...

Functional precision oncology gives physicians the data they need to make better decisions about each patient’s care.

Oncology

From promise to practice: What must happen next for genetic ...

The systems needed to deliver GBT testing consistently across the NHS are still evolving to keep pace with these scientific advances.

How AI is advancing patient subgroup identification in oncol...

Why precision biomarkers will change the future of breast ca...

Clinical Trials Round-Up: July/August 2026

Establishing ctDNA as a validated primary surrogate endpoint

Bridging the cancer drug development gap: AI-driven precisio...

From promise to practice: What must happen next for genetic ...

Flagship joins three biotechs together to form Etcelera

Discover a new era of healthcare panel engagement: Grounded ...

precision oncology

Editor's Picks